Retention of in vivo antipyrimidine effects of brequinar sodium (DUP-785; NSC 368390) in murine liver, bone marrow and colon cancer
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 39 (1), 135-144
- https://doi.org/10.1016/0006-2952(90)90657-7
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- DUP 785 (NSC 368390): Schedule-dependency of growth-inhibitory and antipyrimidine effectsBiochemical Pharmacology, 1988
- In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracilBritish Journal of Cancer, 1988
- Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurinBiochemical Pharmacology, 1988
- Inhibition of pyrimidine de novo synthesis by DUP-785 (NSC 368390)Investigational New Drugs, 1987
- Tissue homogenization using a micro-dismembrator for the measurement of enzyme activitiesClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Separation of 5-fluorouracil and uracil by ion-pair reversed-phase high-performance liquid chromatography on a column with porous polymeric packingJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Effect of Uridine on the Metabolism of 5-Fluorouracil in the CD8F1 Murine Mammary Carcinoma SystemPharmaceutical Research, 1984
- Pyrimidine Metabolism in Rat Brain Cortex and LiverPublished by Springer Nature ,1984
- Pyrimidine Nucleotide Biosynthesis in Animals: Genes, Enzymes, and Regulation of UMP BiosynthesisAnnual Review of Biochemistry, 1980
- The cellular location of dihydroorotate dehydrogenase: Relation to de novo biosynthesis of pyrimidinesArchives of Biochemistry and Biophysics, 1976